Latest Prostate cancer Stories
ROCKLAND, Massachusetts, July 29, 2014 /PRNewswire/ -- - First patient begins treatment in an international Phase II study investigating the efficacy
Individuals diagnosed with a covered Cancer on or prior to October 12, 2012 are included in the October 12, 2014 deadline. Port Washington, NY (PRWEB) July 28,
Discovery Accepted into NCI Drug Development Program for Clinical Trials Philadelphia, PA (PRWEB) July 28, 2014 An estimated 68,000 women and men in
Phase I studies start in 2015 NEW HAVEN, Conn., July 25, 2014 /PRNewswire/ -- Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd.
Transparency Market Research published a new report "Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014
New product offers treatment to significant unmet medical need in supportive cancer care DALLAS and NEW YORK, July 22, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC.
"These positive results enable management to remain optimistic about our ambitious G-202 clinical development program"- Dr.
For the first time ever, Prostate cancer patients can complete a survey describing how their diagnosis changed their lives. New York, NY (PRWEB) July 16, 2014
DCVax®-Direct Phase II Trial Preparations and Manufacturing Expansion Underway BETHESDA, Md., July 16, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology
- The word or words serving to define another word or expression, as in a dictionary entry.
More Images (2 images) »